Viewing Study NCT00743054


Ignite Creation Date: 2025-12-18 @ 4:53 AM
Ignite Modification Date: 2025-12-18 @ 4:53 AM
Study NCT ID: NCT00743054
Status: None
Last Update Posted: 2015-05-21 00:00:00
First Post: 2008-08-27 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: microRNA Expression in Renal Cell Carcinoma
Sponsor: None
Organization:

Study Overview

Official Title: microRNA Expression in Renal Cell Carcinoma
Status: None
Status Verified Date: 2015-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients.

MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis.

In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: